Correlation Between Cizzle Biotechnology and Thales

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cizzle Biotechnology and Thales at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cizzle Biotechnology and Thales into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cizzle Biotechnology Holdings and Thales, you can compare the effects of market volatilities on Cizzle Biotechnology and Thales and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cizzle Biotechnology with a short position of Thales. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cizzle Biotechnology and Thales.

Diversification Opportunities for Cizzle Biotechnology and Thales

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Cizzle and Thales is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Cizzle Biotechnology Holdings and Thales in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Thales and Cizzle Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cizzle Biotechnology Holdings are associated (or correlated) with Thales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Thales has no effect on the direction of Cizzle Biotechnology i.e., Cizzle Biotechnology and Thales go up and down completely randomly.

Pair Corralation between Cizzle Biotechnology and Thales

Assuming the 90 days trading horizon Cizzle Biotechnology Holdings is expected to generate 2.34 times more return on investment than Thales. However, Cizzle Biotechnology is 2.34 times more volatile than Thales. It trades about 0.04 of its potential returns per unit of risk. Thales is currently generating about -0.08 per unit of risk. If you would invest  165.00  in Cizzle Biotechnology Holdings on September 3, 2024 and sell it today you would earn a total of  15.00  from holding Cizzle Biotechnology Holdings or generate 9.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cizzle Biotechnology Holdings  vs.  Thales

 Performance 
       Timeline  
Cizzle Biotechnology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point.
Thales 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Thales has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Thales is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Cizzle Biotechnology and Thales Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cizzle Biotechnology and Thales

The main advantage of trading using opposite Cizzle Biotechnology and Thales positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cizzle Biotechnology position performs unexpectedly, Thales can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thales will offset losses from the drop in Thales' long position.
The idea behind Cizzle Biotechnology Holdings and Thales pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation